title: Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
abstract: X-linked myotubular myopathy (MTM) is a severe neuromuscular disease of infancy caused by mutations of MTM1, which encodes the phosphoinositide lipid phosphatase, myotubularin. The Mtm1 knockout (KO) mouse has a severe phenotype and its short lifespan (8 weeks) makes it a challenge to use as a model in the testing of certain preclinical therapeutics. Many MTM patients succumb early in life, but some have a more favorable prognosis. We used human genotype-phenotype correlation data to develop a myotubularin-deficient mouse model with a less severe phenotype than is seen in Mtm1 KO mice. We modeled the human c.205C>T point mutation in Mtm1 exon 4, which is predicted to introduce the p.R69C missense change in myotubularin. Hemizygous male Mtm1 p.R69C mice develop early muscle atrophy prior to the onset of weakness at 2 months. The median survival period is 66 weeks. Histopathology shows small myofibers with centrally placed nuclei. Myotubularin protein is undetectably low because the introduced c.205C>T base change induced exon 4 skipping in most mRNAs, leading to premature termination of myotubularin translation. Some full-length Mtm1 mRNA bearing the mutation is present, which provides enough myotubularin activity to account for the relatively mild phenotype, as Mtm1 KO and Mtm1 p.R69C mice have similar muscle phosphatidylinositol 3-phosphate levels. These data explain the basis for phenotypic variability among human patients with MTM1 p.R69C mutations and establish the Mtm1 p.R69C mouse as a valuable model for the disease, as its less severe phenotype will expand the scope of testable preclinical therapies.
authors: The Research Institute, Nationwide Children’s Hospital, Columbus, OH 43205, USA. christopher.pierson@nationwidechildrens.org
authors: Christopher R
authors: CR
authors: Pierson
authors: Ashley N
authors: AN
authors: Dulin-Smith
authors: Ashley N
authors: AN
authors: Durban
authors: Morgan L
authors: ML
authors: Marshall
authors: Jordan T
authors: JT
authors: Marshall
authors: Andrew D
authors: AD
authors: Snyder
authors: Nada
authors: N
authors: Naiyer
authors: Jordan T
authors: JT
authors: Gladman
authors: Dawn S
authors: DS
authors: Chandler
authors: Michael W
authors: MW
authors: Lawlor
authors: Anna
authors: A
authors: Buj-Bello
authors: James J
authors: JJ
authors: Dowling
authors: Alan H
authors: AH
authors: Beggs
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D004195:Disease Models, Animal; D005091:Exons / Q000235:genetics*; D005260:Female; D056726:Genetic Association Studies; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018482:Muscle, Skeletal / Q000378:metabolism; D020125:Mutation, Missense / Q000235:genetics; D020914:Myopathies, Structural, Congenital / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology; D010641:Phenotype; D018129:Phosphatidylinositol Phosphates / Q000378:metabolism; D017354:Point Mutation / Q000235:genetics*; D054558:Protein Tyrosine Phosphatases, Non-Receptor / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism
chemical_list: D018129:Phosphatidylinositol Phosphates; D054558:Protein Tyrosine Phosphatases, Non-Receptor; C099588:myotubularin; D002118:Calcium